chrisvoncsefalvay/vaers-outcomes huggingface dataset:
arm ache; shoulder ache; neck ache; A spontaneous report was received from a Consumer concerning an unknown patient of  unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced arm ache,neck ache and shoulder aches.  The patient's medical history was not provided. Concomitant medications history was not provided.  On  15 Jan 2021  the patient received dose of  mRNA-1273 (Lot number: unknown)for prophylaxis of COVID-19 infection.  After the administration of vaccine the patient experienced ache,neck ache and shoulder aches.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events experienced a  ache,neck ache and shoulder aches was considered as unknown at th e time of the report .; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Fever; Nausea; Dizzy; Full body numbness; Achy; Headache; Stomach ache; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8733) via an unspecified route of administration in the right arm on 08Apr2021 at 14:00 (at the age of 54 year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. Prior to vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine, liothyronine (NP THYROID) from an unknown date for unknown indication and unknown if ongoing. The patient previously took local anesthesia (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6202) via an unspecified route of administration in the left arm on 11Mar2021 at 16:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. On 09Apr2021 at 15:00, the patient experienced fever, nausea, dizzy, full body numbness, achy, headache and stomach ache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, nausea, dizzy, full body numbness and achy were recovered with sequelae on an unknown date in 2021 while, the clinical outcome of the events headache and stomach ache were not recovered at the time of this report.
felt little queasy like and it is got a little worse this afternoon at the later in the afternoon last couple of hours; little pressure in the chest; some discomfort on the left side of my stomach; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 78 year-old male patient received bnt162b2 (BNT162B2), administration date 28Aug2021 16:00 (Batch/Lot number: unknown) at the age of 78 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: METOPROLOL TARTRATE; XARELTO; ATORVASTATIN CALCIUM; GLIPIZIDE; VITAMIN B COMPLEX; PENTOXIFILLINE; ASPIRIN (E.C.); PROTONIX [OMEPRAZOLE]. The following information was reported: NAUSEA (non-serious) with onset Aug2021, outcome "unknown", described as "felt little queasy like and it is got a little worse this afternoon at the later in the afternoon last couple of hours"; CHEST DISCOMFORT (non-serious) with onset Aug2021, outcome "unknown", described as "little pressure in the chest"; ABDOMINAL DISCOMFORT (non-serious) with onset Aug2021, outcome "unknown", described as "some discomfort on the left side of my stomach". Therapeutic measures were taken as a result of nausea, chest discomfort, abdominal discomfort treated with Aspirin 325mg, it has a sodium bicarbonate acid.  Additional information: Consumer stated, "Novolog and some that's on a sliding scale as needed, B-50 once a day."(further clarification unknown, hence not captured in tab). Patient stated, No test done in the last two weeks, it had been about a six weeks ago since I have had a last lab work." No prior vaccination (within Four weeks).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Developed swelling and redness Rt deltoid 12 cm x 14 cm.
Tetanus shot after first dose; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (Due for her second shot on 1April2021, of which we was denied) and TETANUS (Tetanus shot after first dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No recorded medical history). Concomitant products included TETANUS VACCINE TOXOID (TETANUS VACCIN) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OFF LABEL USE (Due for her second shot on 1April2021, of which we was denied) and TETANUS (Tetanus shot after first dose). At the time of the report, OFF LABEL USE (Due for her second shot on 1April2021, of which we was denied) had resolved and TETANUS (Tetanus shot after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.; Sender's Comments: Based on reporter's causality the event is assessed as non-applicable to mRNA-1273.
The patient had a herald patch which was a precursor to developing Pityriasis Rosea; fever; chills; headaches; This spontaneous case was reported by a consumer and describes the occurrence of PITYRIASIS ROSEA (The patient had a herald patch which was a precursor to developing Pityriasis Rosea), PYREXIA (fever), CHILLS (chills) and HEADACHE (headaches) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H2A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: pfizer (2nd dose) and pfizer (1st dose). Past adverse reactions to the above products included No adverse reaction with pfizer and pfizer.    On 23-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Nov-2021, the patient experienced PYREXIA (fever), CHILLS (chills) and HEADACHE (headaches). On 30-Nov-2021, the patient experienced PITYRIASIS ROSEA (The patient had a herald patch which was a precursor to developing Pityriasis Rosea). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency. On 24-Nov-2021, PYREXIA (fever), CHILLS (chills) and HEADACHE (headaches) had resolved. At the time of the report, PITYRIASIS ROSEA (The patient had a herald patch which was a precursor to developing Pityriasis Rosea) had not resolved.            Concomitant medications were not reported.  Patient noticed dry patches on back and patches had gotten bigger. On 13-DEC-2021, he went to dermatologist. The doctor indicated that he had a herald patch which was a precursor to developing Pityriasis Rosea. It was look like he was in between stages and once he had Pityriasis Rosea it could last 2 to 6 months before clearing.
1. When did your symptoms start? 3/7/21 2. What symptoms have you experienced? Fever, chills, SOB & wheezing, fatigue. Patient states that today she is experinecing nausea, slight nasal drip and a severe headache & continued fevers.
Pt reports feeling dizzy and lightheaded & flush about 30-45 mins after vaccination. Pt reports that flush feeling resolved after 30 min however the dizziness & lightheadedness persisted. Pt ate lunch and did not feel any better and reported s/s to staff v/s were taken and were stable. Pt was given water and brought to lay down for continued observation
got a booster dose of the Moderna vaccine that was expired.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got a booster dose of the Moderna vaccine that was expired.) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (got a booster dose of the Moderna vaccine that was expired.). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (got a booster dose of the Moderna vaccine that was expired.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication was reported.
Sept, 2022: Started having jaw pain when chewing crunchy food. Oct.  31, 2022: Loss of sight in Right Eye occurred. Nov. 3, 2022:  Retina capillary infiltrates observed by Dr.   Possible Eye Stroke .  Admitted to the                             local hospital through the ER.  High dose I.V. steroid began and Stroke testing protocol                           initiated.   EKG, CAT scan, Electrocardiogram all normal.                            Abnormal Blood Tests detected: High ESR and High CRP Nov.4, 2022: Biopsy of Right Temporal Artery performed Nov.7, 2022:  Dismissed from Hospital.  High dose steroid (60 mg/day) medication prescribed. REPORT OF RIGHT TEMPERAL ARTERY BIOPSY:                  There is chronic arteritis with focal microcalcification and disruptive elastic membrane involving a small arterial branch.  No Giant Cells are found.                 DIAGNOSIS:   Temperal Arteritis                            An autoimmune condition with antibodies attaching to white blood cells resulting in giant cells that infiltrate and cause blockage of blood flow                             through capillaries resulting in death of cells in the eye retina or paralysis and possible death if infiltrate the brain.  12-01-2022:  Received 5th COVID 19 dose per physician order.  1-13-2023:  Steroid (Prednisone) dosage reduced to 50 mg / day.  Rheumatologist currently directing steroid therapy:    MD         Presnisone Taper plan is to be off steroid by the end of summer.
This spontaneous report as received from a consumer regarding  unspecified female patients of unknown age. The information on medication history, concurrent conditions, concomitant medicaitons, drug allergies and reactions were unknown. On unknown dates, the patients were vaccinated with GARDASIL (dose, units, frequency, batch and lot# number, expiry date were unknown) for prophylaxis. Other suspect therapy include CERVARIX. On unknown dates, 879 patients experienced disability (from an unspecified adverse event), 99 patients died, 5352 patients did not recover (from an unspecified adverse event), 500 patients had abnormal papsmear, 202 patients experienced cervical dysplasia, 57 patients experienced cervix carcinoma, 502 patients had adverse event which was life threatening, 9545 patients had to visit emergency room (from an unspecified adverse event), 2717 patients were hospitalized and 218 patients extended the hospital stay (from an unspecified adverse event), 3625 experienced serious adverse events (from an unspecified medically significant adverse event), 25636 experienced non serious adverse events. The outcome of "disability (from an unspecified adverse event)", abnormal papsmear, cervical dysplasia, cervix carcinoma, "adverse event which was life threatening", "visit emergency room (from an unspecified adverse event)", "hospitalized and extended the hospital stay (from an unspecified adverse event)", unspecified medically significant adverse event and non serious adverse event was unknown. Causality assessment was unknown. Upon internal review, the events cervix carcinoma was determined to be medically significant. This is one of the multiple reports from the same reporter.
She felt achey; Nauseous; Headache; Low fever; Arm pain; This is a spontaneous report from a contactable other health professional (patient's parent). A 25-year-old female patient (reporter's daughter) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration at 25-year-old on 09Mar2021 at 09:30 am (batch/lot number and expiration date not reported) at SINGLE DOSE for COVID-19 immunisation. The patient's medical history included borderline obese. Concomitant medications were not reported. On 09Mar2021 at 15:30 the patient experienced that she was going to take nap because she felt achey, nauseous, headache, low fever, and had arm pain. The outcome of the events was unknown.  No follow-up attempts are possible, information about batch/lot number cannot be obtained.
-Redness/swelling of left, upper arm - Generalized pain, felt ill - Patient took diphenhydramine and ibuprofen.
Pt passed out at approx 11:35am - face was very flushed, skin sweaty/clammy. Once she came to she vomited x 2. Per pt she hadn't had breakfast or fluids. Monitored for 30 min in exam room without any complications.
This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. On 21-NOV-2018, the patient was inadvertently vaccinated with expired RECOMBIVAX HB lot # L045117 with expiration date 06-OCT-2018, intramuscularly, for prophylaxis (dose was not reported). No adverse effects were reported.
Gave the immumization ordered 4/5/05: DTaP, IPV and MMR #3. Right arm developed redness, swelling, tenderness. Treatment: seen & treated 4/7/04 at 1 pm with doctor: warm soaks, elevation & Keflex.
About 2 months after my COVID-19 vaccination it was brought to my attention that my blood pressure was running high. I changed my diet to low sodium and began monitoring my blood pressure. These things have slightly improved my blood pressure but haven't corrected it entirely. I have also been experiencing heart palpitations daily and low grade fever off and on. I am currently seeing multiple specialists to try and get answers.
3:00 vax given 29DEC94; 6:00 severe itching-given DPH, used calamine lotion, rash on back & front of trunk; Friday AM itching cont DPH q 6 hrs; 1JAN95 pin head lesions noted on trunk; pt saw MD 5JAN95 who felt atypical 2ndary case chickenpo
I tested positive on November 29 I had fever, ache, cough, and sore throat. This lasted until December 1 and I lost my smell and taste for 11 days. I did take MOTRIN periodically for the fever. On December 9 I tested negative and was fully recovered.
Arm was hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was hurting) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was hurting). At the time of the report, PAIN IN EXTREMITY (Arm was hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Joint and muscle aches, skin acne, nocturnal myoclonus, mood swings, difficulty concentration, cramps on legs, low level of energy, frequent headaches, stiffness, decreased libido, numbness of legs, low back pains, sores chest. Adverse events started while performing duties overseas, but due to the limited availability of medical facilities and the mission demands, it was not until I returned to my Home of Record on Jun 04, that medical assistance/treatment was started. Unable to furnish this information, since those vaccines were done by the military personnel while in preparation to ship to overseas.
Patient came in for a first dose Pfizer COVID-19 vaccine. Confirmed with patient this is his first dose. After billing later, we found out that this is his third dose. Patient have received 2 dose else where
Client blew his car horn to alert the nurse that he was not feeling well.  Client was diaphoretic with labored breathing.  Client was asked to turn on AC and lie back in car seat and slow his breathing if possible.  Client was asked if he had anxiety and he stated yes.  He was asked if he had any underlying conditions and/or was he allergic to anything and he replied no.
Friday my arm started hurting as expected. By the time I went to bed I had cold chills and body aches. This lasted for several hours despite taking tylenol. I took my temp but it was normal. Saturday my husband called off to take care of me. I slept in several hours and woke up with sever arm pain and body aches. I took advil and soaked in a warm bath. This helped and I was able to join my family for dinner. Last night at 3am I woke up with body aches again. I took my temperature and it was up to 100.8. My arm is also swollen and hard with bruising a few inches below the injection site.
numbness surrounding mouth similar to when she gets B12 injections.  No SBO, trouble swallow, etc.
This is a spontaneous report from a contactable nurse received via a Pfizer Sales Representative. A female patient of an unspecified age and ethnicity received TRUMENBA, via an unspecified route of administration on an unspecified date at single dose. The patient medical history and concomitant medications were not reported. The patient experienced soreness in her arm when they administered the vaccine in on an unspecified date with outcome of not recovered. Follow-up (01-APR-2016): Follow-up attempts are completed. No further information is expected.
Chest pain this morning.; Nauseated since last night; A little headache since last night; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain this morning.), NAUSEA (Nauseated since last night) and HEADACHE (A little headache since last night) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. QQ1N7121A, Q37C21A, 038B21A and U36AZ1A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2022, the patient experienced NAUSEA (Nauseated since last night) and HEADACHE (A little headache since last night). On 23-Apr-2022, the patient experienced CHEST PAIN (Chest pain this morning.). On 22-Apr-2022, NAUSEA (Nauseated since last night) and HEADACHE (A little headache since last night) had resolved. On 23-Apr-2022, CHEST PAIN (Chest pain this morning.) had resolved.            Vaccine administered date of second Booster was reported as 21 Apr 2021.  It was reported that patient had never had COVID positive test nor diagnosis.  No concomitant medication were provided.  No treatment medication were provided.
Persistent pain in arm at injection site for 2 months. Did not respond to MEDROL dosepak or Ibuprofen.
Patient received vaccines at approximately 10 AM. Became extremely fussy about 30 minutes later. Parents administered Tylenol .8cc at 11 AM; patient still inconsolable. No other symptoms noted. Patient returned to office at approximately 2 PM, examined by Dr.; Motrin 50 mg and Benadryl 1 1/2 tsp administered. Upon return, patient was resting in mom's arms, not crying but a little fussy.
felt nauseous and dizzy; sensitive to light; low grade fever about 99.9; no energy today; Her first dose injection site has turned red again; tingling in her neck, tingling went down to her hands; a taste in her mouth; SORE ARM FOR SEVERAL WEEKS WITH A BRUISE; very painful; a rash all over her arm; A spontaneous report was received from a consumer concerning a 55-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events a sore arm for several weeks with a bruise, a rash all over her arm, very painful, tingling in her neck, tingling went down to her hands, a taste in her mouth, felt nauseous and dizzy, she cannot move her arm as it hurts so bad, she is having a hard time concentrating, sensitive to light, low grade fever about 99.9, no energy today, her first dose injection site has turned red again and it looks like the rash is about to start.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 21 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 026L20A) via unknown route for prophylaxis of COVID-19 infection. On 19 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 011M20A) via unknown route for prophylaxis of COVID-19 infection.  On 31 Jan 2021, the patient experienced the event(s) a sore arm for several weeks with a bruise, a rash all over her arm, very painful. On 19 Feb 2021, the patient experienced the event(s) tingling in her neck, tingling went down to her hands, a taste in her mouth, felt nauseous and dizzy. On 20 Feb 2021, the patient experienced the event(s) she cannot move her arm as it hurts so bad, she is having a hard time concentrating, sensitive to light, low grade fever about 99.9, no energy today, her first dose injection site has turned red again and it looks like the rash is about to start.  Treatment details included She did take some ibuprofen (for her back and knee pain) but has not taking any Ibuprofen for, the second dose. She has taken Benadryl post vaccination of both doses.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), a sore arm for several weeks with a bruise, a rash all over her arm, very painful, tingling in her neck, tingling went down to her hands, a taste in her mouth, felt nauseous and dizzy, she cannot move her arm as it hurts so bad, she is having a hard time concentrating, sensitive to light, low grade fever about 99, 9, no energy today, her first dose injection site has turned red again and it looks like the rash is about to start was unknown.